References
- Bataille R., Harousseau J. L. Multiple myeloma. N Eng J Med. 1997; 336: 1657–64
- Jagannath S., Tricot G., Barlogie B. Autotrans‐plants in multiple myeloma: pushing the envelope. Hematol Onc Clin N Am. 1997; 11: 363–80
- Passweg J. R., Rowlings P. A., Armitage J. O., . Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry — North America. Clinical Transplants, J. M. Cecka, P. I. Teraskaki, et al. UCLA Tissue Typing Laboratory, Los Angeles, California 1995; 117–127
- Attal M., Harrouseau J. L., Stoppa A. M., et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med. 1996; 335: 91–7
- Barlogie B., Jagannath S., Vesole D. H., et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma blood. BLOOD. 1997; 89: 789–93
- Blade J., San Miguel J. E., Fontanillas M., et al. Survival of multiple myeloma patients who are potential candidates for early high‐dose intensification/autotransplantation who were conventionally treated. J Clin Oncol. 1996; 14: 2167–73
- Brook R. H., Chassin M. R., Fink A., et al. A method for the detailed assessment of the appropriateness of medical technologies. Intl J Tech Assess Health Care. 1986; 2: 53–63
- Jones J., Hunter D. Consensus methods for medical and health services research. Br Med J. 1995; 311: 376–80
- Woolf S. H. Practice guidelines, a new reality in medicine, I: recent developments; and II. Methods of developing guidelines. Arch Intern Med. 1990 and 1992; 150: 1811–8, and 152, 94–52
- Park R. E., Fink A., Brook R. H., et al. Physician ratings of appropriate indications for six medical and surgical procedures. Am J Publ Health. 1986; 76: 766–72
- Durie B. G. M, Salmon S. E. A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975; 36: 842–54
- Brook R. H. The RAND/UCLA appropriateness method. Clinical practice guideline development: methodology perspectives, K. A. McCormick, S. R. Moore, R. A. Siegel. Pub. No. 95–0009, U. S. Dept. of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Office of the Forum for Quality and Effectiveness in Health Care, Rockville, MD 1994; 59–70, also available as Brook R. H. The RAND/UCLA appropriateness method, pp 59–70. Santa Monica, CA: Rand Corporation
- Shekelle P. G., Chassin M. R., Park R. E. Evidence for the validity of criteria for performing carotoid endarterectomy. Int J Tech Assessment in Health Care.
- Kravitz R. L., Laouri M., Kahan J. P., et al. Valididy of criteria used for detecting underuse of coronary revascu‐larization. JAMA. 1995; 274: 632–8
- Selby J. V. B., Fireman B. H., Lundstrom R. J., et al. Variation among hospitals in coronary‐angiography practices and outcomes after myocardial infarction in a large health maintenance organization. N Eng J Med. 1996; 335: 1888–96
- Shekelle P. G., Kahan J. P., Bernstein S. J., et al. Reproducibility of the method to identify the overuse and underuse of medical procedures. N Eng J Med. 1998; 338: 1888–95
- Barlogie B., Jagannath S., Vesole D. H., et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood. 1997; 89: 789–93
- Gale R. P., Park R. E., Dubois R., et al. Delphi‐Panel analysis of appropriateness of high‐dose chemotherapy and blood cell or bone autotransplants in diffuse large‐cell lymphoma. Leuk and Lymph.